DEC 19, 2018 5:12 PM PST

Bipolar Disorder? No Problem! Try Probiotics

WRITTEN BY: Nicholas Breehl

In a recent study conducted at the American College of Neuropsychopharmacology, scientists have revealed the benefits of probiotics – good bacteria – and their positive influence on individuals diagnosed with bipolar disorder. To date, the most prevalent form of treatment is via psychotherapy and prescription medications such as mood stabilizers and antipsychotics.

In the United States, around 3 million individuals are diagnosed each year with bipolar disorder. Bipolar disorder is identified by severe changes in mood ranging from a state of depression to mania. In a recent publication, researchers discuss the emerging field of probiotic research and how it can impact the outcome of patients with bipolar disorder. Probiotics are non-pathogenic bacteria residing in the gut flora. Probiotics have been shown to increase the overall health of their host.

The study, led by Faith Dickerson in collaboration with colleagues at Baltimore Maryland’s Sheppard Pratt Health System, provides data supporting reduced inflammation of the gut after probiotic supplementations are administered. Inflammation of the intestine is a known trigger that exacerbates the effects of bipolar disorder.

The gastrointestinal (GI) tract and its function are strongly linked to the central nervous system; the relationship is known as the GBA or the gut-brain axis. This axis is the main terminal for communications between the endocrine, immune, and autonomic nervous systems. Studies have provided evidence that the GBA is highly influenced when the gut microbiome and the GI tract are off balance. Additionally, data exists revealing that allergies, autoimmune disorders, and psychiatric disorders are linked to the health of the bacteria residing in the gut.

Due to the swelling evidence of how inflammation impacts the effectiveness of the GBA, the researchers created a probiotic supplement to mitigate the inflammation caused by microbial imbalances in the gut. An experimental group of patients was observed over six months to determine the effects of the supplement. The patients were from a group of individuals recently hospitalized for mania. The scientists recorded changes in the patient’s mood and immune system over the duration.

Patients, given either the placebo supplement or the active probiotic, were monitored for baseline changes in their health and mood. The results display those receiving the developed probiotic supplement, on average, had fewer return visits to the hospital than those taking the placebo. The patients receiving the probiotics also did not require as much in-patient treatment. The scientists record that those with the best results were patients who, at first, had the highest inflammation. The team hopes that these results will begin to influence physicians’ decisions to incorporate the use of probiotics when treating individuals with bipolar disorder.

Sources: American College of Neuropsychopharmacology, Science Daily, YouTube

About the Author
You May Also Like
AUG 24, 2020
Drug Discovery & Development
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
AUG 24, 2020
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
The US Food and Drug Agency (FDA) has given emergency approval for expanded use of antibody-rich blood plasma to help th ...
SEP 01, 2020
Immunology
Cell Atlas of Mosquito Immunology Reveals New Avenues for Eradicating Malaria
SEP 01, 2020
Cell Atlas of Mosquito Immunology Reveals New Avenues for Eradicating Malaria
Malaria is one of the biggest ongoing threats to global health — over 200 million were infected and almost half a ...
SEP 13, 2020
Drug Discovery & Development
Scientists Find Way to Reduce Inflammation from Vaccines
SEP 13, 2020
Scientists Find Way to Reduce Inflammation from Vaccines
Researchers from the University of Chicago have found a new way to reduce vaccine-related inflammation from adjuvants, a ...
OCT 22, 2020
Immunology
Migraines: Dark Times and (Pharmaceutical) Rays of Hope
OCT 22, 2020
Migraines: Dark Times and (Pharmaceutical) Rays of Hope
Despite being commonly used interchangeably, headaches and migraines are worlds apart. Migraines are by far much more pr ...
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
NOV 25, 2020
Immunology
The History of vaccines
NOV 25, 2020
The History of vaccines
Everyone worldwide is sitting with anticipation, waiting for the right vaccine candidate for the coronavirus outbreak, h ...
Loading Comments...